The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 17, 2016

Filed:

Sep. 20, 2013
Applicant:

Teva Pharmaceutical Industries, Ltd., Petach-Tikva, IL;

Inventors:

Muhammad Safadi, Nazareth, IL;

Daniella Licht, Givat Shmuel, IL;

Ioana Lovinger, Kfar-Saba, IL;

Aharon M. Eyal, Jerusalem, IL;

Tomas Fristedt, Helsingborg, SE;

Karl Jansson, Dalby, SE;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 209/34 (2006.01); C07D 471/10 (2006.01); C07D 209/42 (2006.01); A61K 31/4704 (2006.01); B65B 25/00 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 31/438 (2006.01);
U.S. Cl.
CPC ...
B65B 25/00 (2013.01); A61K 9/1623 (2013.01); A61K 9/2004 (2013.01); A61K 9/2018 (2013.01); A61K 31/438 (2013.01); A61K 31/4704 (2013.01); C07D 209/34 (2013.01); C07D 209/42 (2013.01); C07D 471/10 (2013.01); Y10T 436/145555 (2015.01);
Abstract

The subject invention provides a pharmaceutical composition comprising N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide or the salt thereof; a pharmaceutically acceptable carrier; and not more than 0.5% w/w relative to N-ethyl-N-phenyl-1,2,-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide of 2-Chloro-6-(1-ethyl-N-methyl-2-oxoindoline-3-carboxamido)benzoic acid, 1H,3H-spiro[5-chloro-1-methylquinoline-2,4-dione-3,3'-[1]ethylindolin-[2]-one], or 5-Chloro-N-ethyl-3-hydroxy-1-methyl-2,4-dioxo-N-phenyl-1,2,3,4-tetrahydro-quinoline-3-carboxamide.


Find Patent Forward Citations

Loading…